Mode
Text Size
Log in / Sign up

Prenatal ultrasound findings and NIPS may facilitate identification of 15q duplication syndromeNew prenatal screening may help identify 15q duplication syndrome earlier

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that FGR and polyhydramnios with additional ultrasound markers may warrant further evaluation for Dup15q syndrome.

This case report combined with a pooled analysis of 35 cases (1 patient and 34 literature cases) explores the prenatal ultrasound findings and identification potential for 15q duplication syndrome. The analysis focuses on identifying markers that may facilitate prenatal diagnosis for this condition.

The synthesis of 34 prenatal cases identified several ultrasound findings, including polyhydramnios, fetal growth restriction (FGR), cardiac abnormalities, dysmorphic features, and abnormal ultrasound soft markers. The authors suggest that non-invasive prenatal screening (NIPS) may facilitate the prenatal identification of Dup15q syndrome.

Limitations include a limited number of prenatal cases available in the literature and a lack of detailed clinical information in many of those cases. Clinical relevance is noted for the identification of FGR and polyhydramnios, especially when combined with other ultrasound abnormalities, positive NIPS, or a positive family history, which may warrant further etiological evaluation for Dup15q syndrome. NIPS is not a definitive diagnostic tool, and specific ultrasound findings are not pathognomonic.

How this fits prior evidence

This report addresses a gap in the identification of 15q duplication syndrome. While prior coverage has noted that AI tools show high diagnostic accuracy for Autism Spectrum Disorder and that music-based interventions show significant positive effects on social communication and autism-related outcomes, this report focuses on the prenatal identification of 15q duplication syndrome using ultrasound and NIPS.

When a baby is diagnosed with 15q duplication syndrome, it often leads to lifelong challenges like autism and epilepsy. Identifying this condition early during pregnancy can help families prepare for the road ahead. This study looked at how we can spot these signs earlier using modern tools.

Researchers looked at one patient and 34 other cases from medical records. They found that certain signs on an ultrasound, such as an excess of amniotic fluid or limited growth of the fetus, can be early indicators. While these signs alone do not confirm a diagnosis, they can alert doctors to look closer.

The study also highlights that non-invasive prenatal screening (NIPS) can help identify the syndrome before birth. However, because there are so few prenatal cases available in current records, the data is still limited. These findings suggest that a combination of ultrasound results and screening tests can help doctors identify the condition sooner for expecting parents.

What this means for you:
Non-invasive prenatal screening may help identify 15q duplication syndrome earlier during pregnancy.

Common questions

What is 15q duplication syndrome?

It is a genetic condition that can lead to several health issues, including autism spectrum disorder and epilepsy. This study looked at how we can identify the condition earlier during pregnancy using ultrasound findings and non-invasive prenatal screening.

Can doctors find this condition before a baby is born?

Yes, the study suggests that non-invasive prenatal screening (NIPS) can help identify the syndrome before birth. Additionally, certain ultrasound findings like polyhydramnios (too much amniotic fluid) or fetal growth restriction can alert doctors to investigate further.

Are ultrasound findings a guaranteed way to diagnose the condition?

No, specific ultrasound findings are not a definitive way to diagnose the syndrome on their own. However, when findings like growth issues or extra fluid appear alongside other markers, they can help doctors decide when to perform more detailed testing.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Background15q duplication (Dup15q) syndrome is a rare neurodevelopmental disorder characterized by early-onset hypotonia, developmental delay, intellectual disability, symptoms related to autism spectrum disorder and epilepsy. In the absence of specific treatment, prenatal diagnosis is of important clinical significance. However, most reported cases are postnatal cases, whereas prenatal cases are limited and often lack detailed clinical information, making prenatal recognition of this disorder challenging. In this study, we integrated prenatal and postnatal clinical information from the present case with a pooled analysis of published prenatal Dup15q syndrome cases, providing additional insights into the prenatal-to-postnatal phenotypic spectrum of Dup15q syndrome.Case presentationWe report a case of Dup15q syndrome with both prenatal and postnatal clinical data. Although prenatal ultrasound showed polyhydramnios, an abdominal circumference below the 10th percentile, and mild tricuspid regurgitation, no further prenatal genetic testing was performed. After birth, the patient presented with early hypotonia and developmental delay, and the diagnosis was established by genetic testing after a poor response to rehabilitation. We collected 34 prenatal Dup15q syndrome cases through literature review. The results showed that non-invasive prenatal screening (NIPS) may facilitate the prenatal identification of Dup15q syndrome. Prenatal ultrasound findings included polyhydramnios, fetal growth restriction (FGR), cardiac abnormalities, dysmorphic features, and abnormal ultrasound soft markers. The pooled analysis further provided an overview of the prenatal phenotypic spectrum of Dup15q syndrome and suggested that FGR and polyhydramnios, particularly in the presence of additional ultrasound abnormalities, positive NIPS results, or a positive family history, may warrant further etiological evaluation.ConclusionsDup15q syndrome exhibits prominent clinical heterogeneity with nonspecific prenatal manifestations, predisposing patients to missed or delayed diagnosis. By integrating prenatal and postnatal clinical information with pooled prenatal cases, this study provides a broader understanding of the phenotypic spectrum of Dup15q syndrome and may facilitate prenatal counseling and early clinical recognition.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.